Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2025-12-25 @ 2:52 AM
NCT ID: NCT00819533
Eligibility Criteria: Inclusion Criteria: * Male or female subjects, 18 years of age or older at the time of enrollment * Subjects meeting all medical conditions for percutaneous chest aspiration/biopsy with safe path to lesion between ribs, however, not in the breast area in women or men with gynecomastia * Single target pulmonary lesion greater than 10 mm in size (diameter) and depth of lesion greater than 40 mm from the skin * Written informed consent to participate in the study * Ability to comply with the requirements of the study procedures Exclusion Criteria: * Fibrous tissue or cyst in access path (not including target lesion) * Hemophilia, thrombocytopenia, coagulopathy, or other elevated risk for bleeding or abnormal clotting * Use of ticlodipine or similar antithrombotic medication * For subjects taking warfarin or other anticoagulant medication, INR \>1.3 * Pulmonary hypertension, heart failure, renal failure, or blood dyscrasia * Patient is unable to comply with requirements of the procedure, i.e. holding breath * Participation in any prior investigational trial within 30 days of enrollment * Any form of substance abuse (including drug or alcohol abuse), psychiatric disorder, or any chronic condition that could, in the opinion of the investigator, of interfering with the conduct of the study. * Subjects who are uncooperative or cannot follow instructions
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT00819533
Study Brief:
Protocol Section: NCT00819533